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Abstract
Heterogeneous surface expression of Thy-1 in fibroblasts modulates inflammation and may thereby modulate injury and
repair. As a paradigm, patients with idiopathic pulmonary fibrosis, a disease with pathologic features of chronic
inflammation, demonstrate an absence of Thy-1 immunoreactivity within areas of fibrotic activity (fibroblast foci) in contrast
to the predominant Thy-1 expressing fibroblasts in the normal lung. Likewise, Thy-1 deficient mice display more severe lung
fibrosis in response to an inflammatory injury than wildtype littermates. We investigated the role of Thy-1 in the response of
fibroblasts to the pro-inflammatory cytokine TNF-a. Our study demonstrates distinct profiles of TNF-a-activated gene
expression in Thy-1 positive (Thy-1+) and negative (Thy-12) subsets of mouse embryonic fibroblasts (MEF). TNF-a induced a
robust activation of MMP-9, ICAM-1, and the IL-8 promoter driven reporter in Thy-12 MEFs, in contrast to only a modest
increase in Thy-1+ counterparts. Consistently, ectopic expression of Thy-1 in Thy-12 MEFs significantly attenuated TNF-a-
activated gene expression. Mechanistically, TNF-a activated Src family kinase (SFK) only in Thy-12 MEFs. Blockade of SFK
activation abrogated TNF-a-activated gene expression in Thy-12 MEFs, whereas restoration of SFK activation rescued the
TNF-a response in Thy-1+ MEFs. Our findings suggest that Thy-1 down-regulates TNF-a-activated gene expression via
interfering with SFK- and NF-kB-mediated transactivation. The current study provides a novel mechanistic insight to the
distinct roles of fibroblast Thy-1 subsets in inflammation.
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Introduction
Thy-1 is a glycosyl phosphatidylinositol-anchored glycoprotein
that is expressed in a variety of cell types, including T cells,
thymocytes, neurons, endothelial cells, and fibroblasts [1,2,3].
Thy-1 is involved in T cell activation, inflammation, wound
healing, and fibrosis. To mediate these diverse effects, Thy-1
participates in multiple signaling cascades. One of numerous Thy-
1 interacting signaling molecule is Src Family Kinase (SFK). After
T cell receptor activation, thymocytes isolated from Thy-1 null
mice have increased SFK activity and cell proliferation when
compared with thymocytes collected from wild-type mice, which
indicates that Thy-1 inhibits T cell receptor-induced SFK
activation and proliferation of thymocytes [4]. On the other
hand, SFK is transiently activated by thrombospondin-1 in Thy-
1+, but not in Thy-12 rat lung fibroblasts [5]. These contradictory
reports implicate that Thy-1 modulates SFK activity in a manner
dependent upon cellular context.
Accumulating evidence indicates that fibroblasts are important
modulators of inflammation and immunity [6,7,8]. One intriguing
phenomenon observed in fibroblasts is their phenotypic heteroge-
neity based on surface expression of Thy-1 and its subsequent
pathological implications associated with inflammation [9,10,
11,12]. Thy-1 appears to regulate fibroblast responses to inflam-
matory cytokines. Thy-1 subpopulations of orbital fibroblasts differ
in PGE2 and IL-8 production, in that IL-1b induces greater PGE2
expression in Thy-1+ fibroblasts, but stimulates more IL-8 in Thy-
12 fibroblasts [13,14]. Thy-1 subpopulations of primary rat lung
fibroblasts exhibit distinct proliferative responses, signal transduc-
tion, and cell morphology upon exposure to PDGF-AA and IL-1b
[15,16,17]. Thy-12 rat lung fibroblasts also possess a greater ability
to activate latent TGF-b1 in response to pro-fibrotic cytokines and
bleomycin than do their Thy-1+ counterparts [18].
Immunohistochemical analyses of human lung sections reveal
that fibroblasts within fibroblastic foci of idiopathic pulmonary
fibrosis do not express Thy-1, whereas most fibroblasts from
normal lungs are Thy-1+ [19]. In a murine lung model of
bleomycin-induced fibrosis, Thy-1 deficient mice develop more
severe lung fibrosis in comparison to wildtype littermates [19].
These findings underscore the biological significance of fibroblast-
expressed Thy-1 in inflammation-associated fibrogenesis. Howev-
er, the molecular mechanism underlying Thy-1 modulated
inflammatory responses remains largely unknown.
TNF-a is a major pro-inflammatory cytokine. Upon binding to
its receptors on the cell membrane, TNF-a initiates an
inflammatory cascade consisting of increases in COX-2, iNOS,
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inflammatory cells and eventual tissue destruction [20]. TNF-a
activates expression of a panel of inflammation modulators and
executors via activating transcription factors such as NF-kB and
AP-1. Resident fibroblasts in various organs are a major target
cell type for TNF-a to modulate inflammation. For instance,
TNF-a primes lung fibroblasts to produce Th1 type chemokines
in interstitial lung diseases [21], and in rheumatoid arthritis,
TNF-a stimulates secretion of matrix metalloproteinases by
synovial fibroblasts [22]. Among the signaling pathways activated
by TNF-a, SFK activation is required for activation of NF-kB
and the consequent transcriptional activation of TNF-a target
genes, such as ICAM-1 and COX-2 in human epithelial cell lines
[23,24].
The current study investigates whether Thy-1 expression
regulates gene activation by TNF-a in fibroblasts. Our results
indicate that Thy-1 expression in mouse embryonic fibroblasts
(MEF) substantially attenuates gene activation by TNF-a,w h i c h
includes MMP-9, ICAM-1, and a reporter gene controlled by
the human IL-8 promoter. Moreover, SFK activation is required
for TNF-a-activated gene expression in MEFs. Our findings
further suggest that Thy-1 interferes with SFK activation by
TNF-a and thereby inhibits TNF-a-activated gene expression in
MEFs.
Results
Differential expression of the TNF-a-activated genes in
MEF Thy-1 subsets
Thy-1 expression has been implicated in regulating inflamma-
tory responses in fibroblasts. Since TNF-a is a major pro-
inflammatory cytokine, we questioned whether Thy-1 regulates
gene activation by TNF-a in fibroblasts. Sorted subsets of MEFs
based on surface expression of Thy-1 (Thy-12 and Thy-1+) were
serum-starved and exposed to TNF-a (5 ng/ml) for 24 hours.
Expression of MMP-9 and ICAM-1, two TNF-a-activated genes,
were determined by quantitative RT-PCR. TNF-a induced a
robust induction of MMP-9, a 12-fold increase over the control
group in Thy-12 MEF, in contrast to a modest 4-fold increase in
Thy-1+ MEF (Figure 1A). The differential MMP-9 response to
TNF-a emerged as early as 12 hours post exposure with greater
disparity between Thy-1 subsets, a 33-fold increase over control
for Thy-12 MEF vs. a 6-fold increase over control for Thy-1+
MEF (data not shown). A similar profile was observed in ICAM-1
with a 18-fold increase in the mRNA levels of ICAM-1 in TNF-a
stimulated Thy-12 MEF vs. a 4-fold increase in Thy-1+ MEF
(Figure 1B). To confirm the difference in MMP-9 induction in
response to TNF-a, expression of MMP-9 was examined using
gelatin zymography in the conditioned medium collected from the
Figure 1. Differential Expression of MMP-9 and ICAM-1 in TNF-a-stimulated MEF Thy-1 subsets. A) Serum starved Thy-1+ and Thy-12
MEFs were stimulated with TNF-a (5 ng/ml) for 24 hours. Total RNA was isolated from the stimulated MEFs. Quantitative RT-PCR was carried out to
determine the mRNA levels of MMP-9. The fold change of MMP-9 mRNA in the stimulated cells over control was obtained by setting the values from
the untreated MEFs to one. B) The culture conditions were similar to part A except that the mRNA levels of ICAM-1 were determined. C) The
conditioned medium was collected from MEFs exposed to the indicated doses of TNF-a and TGF-b1 for 48 hrs. Gelatin zymography was carried out to
determine the expression MMP-2/-9 in the conditioned medium. A representative gel image from three experiments was shown. D) Thy-1 MEF
subsets were seeded into Matrigel-coated transwell chambers. The cells were stimulated by TNF-a (5 ng/ml) for 24 hours. The invading cells on the
bottom surface of the membrane were stained and enumerated under light microscopy at 4006amplification. The sum of invading cells from 5
randomly selected fields was compared across the groups. The invasion assays were performed in triplicates for each treatment group. Results shown
were mean and standard deviations from at least three independent experiments. *, P value,0.05.
doi:10.1371/journal.pone.0011662.g001
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conditioned medium exhibited distinct TNF-a (5 and 10 ng/ml)
responses t between Thy-1 subsets. MMP-9 expression was
substantially induced by TNF-a in Thy-12 MEFs with a more
than 3-fold increase over control as determined by densitometry,
whereas in comparison there was only a minimal change in MMP-
9 in Thy-1+ MEF (Figure 1C). In contrast, MMP-9 protein was
induced to a similar extent by TGF-b1 (5 and 10 ng/ml) in both
subsets (Figure 1C). The TGF-b1-induced increase in MMP-9
mRNA levels was also comparable between the Thy-1 subsets, a
10-fold increase in Thy-12 MEFs vs. a 12-fold increase in Thy-1+
MEFs in response to 5 ng/ml of TGF-b1 (data not shown).
Neither TNF-a nor TGF-b1 altered MMP-2 expression in the
conditioned medium of MEF Thy-1 subsets (Figure 1C). More
importantly, only Thy-12 MEFs responded to TNF-a with an
increase in invasion through a Matrigel barrier, although Thy-1+
MEFs exhibited greater baseline invasiveness (Figure 1D). The
higher baseline of invasion in Thy-1+ MEFs correlated with a
higher basal expression of MMP-2 at both mRNA and protein
levels (Figure 1, C & D, and data not shown). To validate the Thy-
1-mediated regulation of TNF-a-activated gene expression, we
transiently transfected Thy-12 MEFs with either a backbone
vector or a Thy-1 expressing vector. The transient transfection
resulted in a 30-fold increase in Thy-1 mRNA in Thy-12 MEFs
(data not shown). In agreement with the results from MEF Thy-1
subsets, expression of Thy-1 in Thy-12 MEFs substantially
reduced TNF-a-induced MMP-9 and ICAM-1 to less than 50%
of the increase observed in Thy-12 MEF transfected with the
backbone vector (Fig. 2A). Moreover, TNF-a-induced MMP-9
expression in the conditioned medium was also significantly
reduced (Fig. 2B). Since TNF-a signaling can transcriptionally
activate its target genes, including MMP-9, ICAM-1, and IL-8
through activation of transcription factor NF-kB and AP-1, we
questioned whether Thy-1 expression regulates transcriptional
activation of the TNF-a target promoters [25]. We used the
human IL-8 promoter reporter which harbors the NF-kB and AP-
1 response elements [26]. Indeed, TNF-a induced a 4-fold
increase of the reporter activity in Thy-12 MEFs transfected with
Figure 2. Reduced TNF-a-activated gene expression by Thy-1 expression in Thy-1– fibroblasts. A) Thy-1– MEFs were transiently
transfected with either the Thy-1 expression vector (Thy-1) or the backbone vector (Vec) followed by exposure to TNF-a (5 ng/ml) for 24 hrs. Total
RNA was isolated from the stimulated MEFs. Quantitative RT-PCR was carried out to determine the mRNA levels of MMP-9 and ICAM-1. The fold
change of each mRNA in the stimulated cells over control was obtained by setting the values from the untreated backbone vector transfected Thy-1–
MEFs to one. B) The culture conditions were similar to part A except that the transfected Thy-1– MEFs were exposed to TNF-a (5 ng/ml) for 48 hrs.
The conditioned medium was collected and analyzed for the expression of MMP-2/-9 by gelatin zymography. A representative gel image from three
experiments was shown. C) The culture conditions were similar to part A except that the IL-8-Luc and RL-TK reporters were co-transfected with Thy-1
or the backbone vector. A fold increase in IL-8-Luc by TNF-a (5 ng/ml) was determined by setting the values from the unstimulated Thy-1– MEFs to
one. D) The serum-starved RLE6 variants were stimulated with the indicated doses of TNF-a for 24 hrs. The mRNA levels of MMP-9 were determined
as described in part A. The results were average from two independent experiments. E) Similar to Part D except that MMP-9 expression in the
conditioned medium was determined using gelatin zymogram in RLE6 variants stimulated with TNF-a for 48 hrs. The gel image is representative of
two independent experiments. Vec and V refer to Thy-1– MEFs transfected with the backbone vector. Thy-1 and T refer to Thy-1– MEFs transfected
with the Thy-1 expression vector. In parts A & C, the results shown are the mean and standard deviation from at least three independent
transfections. *, P value,0.05.
doi:10.1371/journal.pone.0011662.g002
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IL-8 promoter was diminished by Thy-1 expression as demon-
strated by only a marginal increase of only 1.5-fold in Thy-12
MEFs transfected with Thy-1 (Fig. 2C). Thy-1-modulated TNF-a-
activated gene expression was also assessed in variants of a rat fetal
lung fibroblast line, the Thy-12 (RLE6.EV) and the Thy-1
overexpressing (RLE6.Thy-1). MMP-9 induction by TNF-a was
examined by qRT-PCR (Figure 2D) and gelatin zymography
(Figure 2E). Similar to Thy-12 MEFs, RLE6.EV responded to
TNF-a with a remarkable increase in MMP-9 (Figure 2, D & E).
MMP-9 expression remained unchanged upon exposure TNF-a in
the RFL6.Thy-1 cells. However, RFL6.Thy-1 cells exhibited
much greater basal MMP-2 and MMP-9 expression than that of
RFL6.EV cells (Figure 2E and data not shown). Nevertheless, with
respect to the TNF-a-activated gene expression, the results from
RFL6.Thy-1 variants corroborated the observations from MEF
Thy-1 subsets in that Thy-1 expression attenuated TNF-a-
activated gene expression in fibroblasts.
SFK activation in TNF-a-stimulated MEF Thy-1 subsets
Several studies have documented that Thy-1 regulates SFK
activity [5,27,28,29]. Activation of SFK plays a critical role in
TNF-a signaling in epithelial cells [23,24]. To explore the
potential interaction between Thy-1 and SFK activation by
TNF-a in MEFs, SFK activity was examined by immunoblots with
an antibody specific for the active form of SFK which is marked by
phosphorylation of tyrosine 416 in c-Src as well as the equivalent
sites in other SFKs. TNF-a stimulated a transient increase in
phosphorylation of SFK only in the Thy-12 subpopulation, which
emerged at 5 minutes post exposure and declined to baseline by 15
minutes (Figure 3A, top panel). On the contrary, TNF-a did not
induce a noticeable change in SFK phosphorylation in Thy-1+
MEFs (Figure 3A, top panel). Immunoblots for SFK protein from
the same blots did not reveal any significant difference in protein
levels of SFK between two subpopulations (Figure 3A, top panel).
Since degradation of I-kBa and the consequent activation of NF-
kB are pivotal steps for TNF-a-activated gene expression [23,24],
we examined whether Thy-1 modulates degradation of I-kBa.
The baseline of the protein levels of I-kBa was similar in the MEF
Thy-1 subpopulations. In addition, the TNF-a-induced degrada-
tion in I-kBa was indistinguishable between the Thy-1 subsets
through 15 minutes post exposure (Figure 3A, bottom panel). We
next sought to determine the role of SFK activation in the distinct
response of MEF Thy-1 subsets to TNF-a by employing PP2, a
SFK selective small molecule inhibitor. MEFs were pretreated
with PP2 (10 mM) for 30 minutes followed by exposure to TNF-a
(5 ng/ml). Surprisingly, PP2 (10 mM) rescued SFK activation in
TNF-a stimulated Thy-1+ MEFs, whereas PP2 exhibited little
effect on SFK phosphorylation in Thy-12 MEFs (Figure 3B).
Moreover, TNF-a stimulated phosphorylation of FAK associated
with SFK only in Thy-12 MEFs (Figure 3C). Because FAK is a
well documented substrate of SFK, elevated phosphorylation of
SFK-associated FAK further supported activation of SFK in Thy-
12 MEFs. More importantly, PP2 increased phosphorylation of
SFK-associated FAK in Thy-1+ MEFs exposed to TNF-a
(Figure 3C), which was consistent with SFK activation by PP2 in
Thy-1+ MEFs (Figure 3B). SFK activity in the MEFs exposed to
the above treatments was further directly measured in vitro using a
Figure 3. TNF-a-mediated activation of SFK in MEF Thy-1 subsets. A) MEF Thy-1 subsets were exposed to TNF-a (5 ng/ml) for 5 and
15minutes. The treated MEFs were lysed and immunoblotted for tyrosine 416 phosphorylated-SFK, total SFK, I-kBa, and b-actin. B) Similar to part A
except that MEF Thy-1 subsets were pretreated with PP2 (10 mM) for 30 minutes, and then exposed to TNF-a (5 ng/ml) for 5 minutes. The cell lysates
were immunoblotted for tyrosine 416 phosphorylated-SFK and total SFK. C) Serum-starved MEFs were exposed to TNF-a (5 ng/ml) 6 PP2 (10 mM) for
5 minutes and cell lysates were immunoprecipitated with an SFK-specific antibody. The level of phosphorylated FAK in SFK-specific antibody
immunoprecipitates was measured by immunoblots with a phosphotyrosine-specific antibody. The blot was then stripped and reprobed with a FAK-
specific antibody to determine the amount of SFK-associated FAK. D) The MEFs were treated and immunoprecipitated with an SFK-specific antibody
as in part C. SFK activity was determined using in vitro SFK assay as described in Methods. Results shown were mean and standard deviations from
three independent experiments. *, P value,0.05. The results represent the average and standard error from three separate assays. The immunoblots
in parts A to C are representative of two independent experiments. ‘‘SFK-P’’ refers to SFK with tyrosine 416 phosphorylated; ‘‘FAK-P’’ refers to FAK
with tyrosine residues phosphorylated.
doi:10.1371/journal.pone.0011662.g003
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associated phosphorylation of SFK-specific peptide substrate only
in Thy-12 MEF, whereas a combination TNF-a and PP2
activated SFK in both Thy-1 subsets (Figure 3D). The in vitro
kinase assays confirmed that PP2, at least in MEFs under the
current experimental conditions, activated rather than inhibited
SFK activity. Consequently, PP2 rescued MMP-9 and ICAM-1
induction by TNF-a in Thy-1+ MEF to a level comparable to that
in Thy-12 MEF (Figure 4, A and B). Rescued induction of MMP-
9 was further confirmed by MMP-9 expression in the conditioned
medium collected from Thy-1+ MEFs exposed to TNF-a
(Figure 4C).
Requirement of SFK activation for TNF-a-activated gene
expression in MEFs
Since PP2 paradoxically rescued SFK activation and induction
of MMP-9 and ICAM-1 by TNF-a in Thy-1+ MEFs, we utilized
another SFK selective inhibitor, SU6656 to determine the role of
SFK activation in TNF-a-activated gene expression in MEF Thy-
1 subsets [30]. SU6656 (20 mM) substantially diminished the TNF-
a-activated expression of MMP-9 and ICAM-1 in both Thy-1
subsets (Figure 5, A and B). Furthermore, elevated MMP-9
expression in the conditioned medium in response to TNF-a was
nearly abrogated by SU6656 in Thy-12 MEFs (Figure 5C). In
contrast to PP2, SU6656 not only failed to activate SFK in Thy-1+
MEFs, but also abrogated TNF-a-mediated SFK activation in
Thy-12 MEFs (Figure 5D). In accord, tyrosine phosphorylation of
SFK-associated FAK, was stimulated only in Thy-12 MEF and
abolished by SU6656 (Figure 5D). To confirm the requirement of
SFK for TNF-a-activated gene expression in MEFs, dominant-
negative Fyn (dnFyn), a member of SFK family, was expressed by
transient transfection to specifically interfere with SFK activation
in Thy-12 MEFs exposed to TNF-a. dnFyn expression substan-
tially reduced induction of MMP-9 and ICAM-1 mRNA by TNF-
a, as a more than 50% decrease was observed when compared to
the Thy-12 MEFs transfected with a backbone vector (Figure 6A).
Similar to Thy-1 expression (Figure 2), dnFyn expression
attenuated TNF-a-mediated activation of the IL-8 promoter in
Thy-12 MEFs (Figure 6B). Moreover, dnFyn expression reduced
induction of MMP-9 in the conditioned medium collected from
TNF-a-stimulated Thy-12 MEFs (Figure 6C). These results
demonstrated a requirement for SFK activation in TNF-a-
activated gene expression in MEF Thy-1 subset.
Requirement of the NF-kB binding site for PP-2-mediated gene
activation in response to TNF-a – To investigate the role for NF-kB
and AP-1 in differential gene activation by TNF-a in Thy-1 subsets
of MEFs, we examine the IL-8 promoter activity with or without
mutations in the NF-kB or AP-1 binding site using reporter assays.
In both Thy-1 subsets, mutational inactivation of the NF-kB
binding site nearly silenced the IL-8 promoter as the IL-8-
LUCmtNF-kB exhibited less than 10% activity of the IL-8-LUCwt
(Figure 7A). Moreover, loss of the NF-kB binding site abrogated
activation of the IL-8 promoter by TNF-a in Thy-12 MEFs. On
the other hand, IL-8-LUCmtAP-1 retained around 30% activity of
the IL-8-LUCwt and exhibited around 2-fold increase upon
exposure to TNF-a in both MEF subsets. These findings implicate
that NF-kB binding mediated transcriptional activation plays a
more critical role in differential activation of the IL-8 promoter by
TNF-a in Thy-1 subsets of MEFs. Because PP2 rescued TNF-a-
activated gene expression in Thy-1+ MEFs (Figure 4), we set to
Figure 4. Rescue of TNF-a-activated gene expression by PP2 in Thy-1+ MEFs. A) Serum-starved MEFs were pre-treated with either DMSO
(solvent control) or PP2 (10 mM) for 30 minutes followed by exposure to TNF-a (5 ng/ml) for 24 hours. Total cellular RNA was isolated and
quantitative RT-PCR was performed to determine the mRNA levels of MMP-9. The fold change of each mRNA was obtained by correction with the
corresponding values of the house keeping gene 36B4 and by setting the values from the control group to one. B) Similar to part A except that the
mRNA levels of ICAM-1 was determined by quantitative RT-PCR. C) MEF Thy-1 subsets were treated as in part A for 48 hrs. The conditioned medium
was collected from each treatment group and processed for gelatin zymography to determine the expression of MMP-9 in the conditioned medium.
‘‘S’’ refers to the solvent DMSO. The results represent the mean and standard deviation from three independent experiments. *, P value,0.05.
doi:10.1371/journal.pone.0011662.g004
Thy-1-Linked TNF-a Signaling
PLoS ONE | www.plosone.org 5 July 2010 | Volume 5 | Issue 7 | e11662determine the role for NF-kB and/or AP-1 binding sites in PP2-
mediated rescue of the IL-8 promoter activation. Consistent with
activation of the TNF-a responsive endogenous genes MMP-9 and
ICAM-1, PP2 rescued activation of the IL-8 promoter by TNF-a
because only the simultaneous exposure to TNF-a and PP2 resulted
ina around 3-foldincreaseintheIL-8-LUCwt reporteractivityover
the control group (Figure 7B). PP2 failed to activate the IL-8-
LUCmtNF-kB in which NF-kB binding was inactivated. In
contrast, the IL-8-LUCmtAP-1 reporter was activated by a
combination of PP2 and TNF-a although the elevated activity of
IL-8-LUCmtAP-1 remained lower than that of IL-8-LUCwt. These
findings suggest that the NF-kB binding site is essential to PP2-
mediated rescue of activation of the IL-8 promoter in Thy-1+
MEFs. To confirm the link between NF-kB bindingto the promoter
and PP2 in Thy-1+ MEFs, we examine the effects of PP2 on the
luciferase reporters that are regulated by tandem multiple copies of
NF-kB or AP-1 binding sites, respectively. Consistent with the
response of the IL-8 promoter variants to PP2, NF-kB-LUC, but
not AP-1-LUC was activated by PP2 in Thy-1+ MEFs exposed to
TNF-a (Figure 7C). Similar to the disparate contribution of NF-kB
and AP-1 binding to activation of the IL-8 promoter by TNF-a,
only NF-kB-LUC, but not AP-1-LUC, was significantly activated
by TNF-a in Thy-12MEFs (Figure 7D). Taken together, these
findings indicate a critical role for NF-kB binding in differential
gene activation by TNF-a in Thy-1 subsets of MEFs.
Discussion
Thy-1 fibroblast subsets appear to behave differently in response
to the inflammatory mediator TNF-a. The current study
investigates the role of Thy-1 in TNF-a-activated gene expression
in MEFs. Our findings indicate that Thy-1+ MEFs exhibit
reduced gene activation, namely MMP-9, ICAM-1 in response to
TNF-a, and a reporter gene controlled by the human IL-8
promoter, when compared to Thy-12 MEFs. Moreover, TNF-a
activates SFK in Thy-12 MEFs, but not in Thy-1+ MEF.
Pharmacologic activation of SFK rescues TNF-a-activated gene
expression in Thy-1+ MEFs, whereas blockade of SFK activation
abrogates TNF-a-activated gene expression in Thy-12 MEFs.
Taken together, these findings suggest that Thy-1 attenuates TNF-
a-activated gene expression via interfering with SFK activation in
fibroblasts, which may contribute to the distinct roles of Thy-1
fibroblast subsets in response to inflammation.
A large body of evidence indicates that Thy-1 expression in
fibroblasts modulates inflammation [1,2,3]. One such paradigm
has been illustrated by the predominance of Thy-12 lung
fibroblasts in pulmonary fibrosis accompanied by inflammation.
Moreover, Thy-12/2 mice exhibit a marked increase in the
severity of lung fibrosis consequent to injury from intratracheal
administration of bleomycin [19]. Our findings reveal that
MEF Thy-1 subsets differ in TNF-a-activated gene expression
Figure 5. Abrogation of TNF-a-activated gene expression by SFK blockade. A & B) Serum-starved MEFs were pre-treated with either DMSO
(solvent control) or SU6656 (20 mM) for 30 minutes followed by exposure to TNF-a (5 ng/ml) for 24 hours. Total cellular RNA was isolated and subject
to quantitative RT-PCR for MMP-9 and ICAM-1 as described in Methods. The fold change of each mRNA was obtained by correction for the
corresponding values of the house keeping gene 36B4 and by setting the values from the control group to one. The results were presented in means
and standard deviations from three independent experiments. *, P value,0.05. C) The conditioned medium was collected from each treatment group
of MEFs as in parts A & B and processed for gelatin zymography as described in Methods. D) Serum-starved MEF were pretreated with SU6656
(20 mM) for 30 minutes followed by exposure to TNF-a for 5 minutes. The exposed cells were then lysed and immunoblotted for tyrosine 416
phosphorylated-SFK, total SFK. The level of phosphorylated FAK in SFK-specific antibody immunoprecipitates was measured by immunoblots using a
phosphotyrosine-specific antibody. The blot was then stripped and reprobed with a FAK-specific antibody to determine the amount of SFK-
associated FAK. ‘‘SFK-P’’ refers to SFK with tyrosine 416 phosphorylated; ‘‘FAK-P’’ refers to FAK with tyrosine residues phosphorylated. A
representative image from at least two independent experiments is presented in parts C and D.
doi:10.1371/journal.pone.0011662.g005
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demonstrate that Thy-1 expression is sufficient to attenuate
TNF-a-activated gene expression (Figure 2). Similarly, TNF-a-
activated MMP-9 expression is robust in the Thy-12 RFL6.EV
while absent in RFL6.Thy-1, although RFL6.Thy-1 cells exhibit
greater basal expression of MMP-2 and MMP-9 than the
RFL6.EV (Figure 2, D & E). Nevertheless, the results from
RFL6 variants are fundamentally in line with that from MEFs,
which strongly suggests that attenuation of TNF-a-activated gene
expression by Thy-1 is a reproducible phenomenon in fibroblasts
isolated from different species. Given the roles of MMP-9 in cell
migration and ICAM-1 in cell-cell interaction, it is conceivable
that Thy-1 modulates mobilization of fibroblasts by TNF-a in
inflammation. In support of this notion, TNF-a induces invasion
only in the Thy-12 MEFs despite greater basal level of invasive
potential in Thy-1+ MEFs (Figure 1D). Higher baseline of
invasion in Thy-1+ MEFs might be attributed higher basal levels
of MMP-2 at the mRNA and protein levels (Figure 1 and data
not shown). Reduced activation of the human IL-8 promoter in
the presence of Thy-1 expression lends further support to this
concept and suggests that Thy-1 expression inhibits TNF-a-
mediated transcriptional activation (Figure 2). Our findings are in
line with a previous study that indicates Thy-12 fibroblasts are
more sensitive to IL-1b than their Thy-1+ counterparts, which
was manifested by greater induction of IL-6 in Thy-12
fibroblasts [17]. Importantly, TNF-a and IL-1b are key cytokines
that mediate injury inflammation and the subsequent fibrosis in
experimental lung fibrosis triggered by bleomycin. Moreover,
Thy-1 limits the ability of fibroblasts to activate latent TGF-b1, a
pivotal modulator of inflammation [18]. Our findings reinforce
the idea that Thy-1 expression in fibroblasts modulates their
responses to inflammatory mediators, which may account for the
more severe lung fibrosis in Thy-1 deficient mice and the
predominance of Thy-12 fibroblasts in the fibroblastic foci in
patients with idiopathic pulmonary fibrosis [19].
Activation of NF-kB is central to TNF-a-mediated cellular
responses. A comparison of the transcriptional activity of the IL-8
promoter and its variants with inactivation of either NF-kB or AP-
1 binding site implicates a greater role for NF-kB in TNF-a-
activated gene expression than AP-1 (Figure 7). Furthermore, NF-
kB appears to be responsible for differential TNF-a-activated gene
expression between Thy-1 subsets because NF-kB-LUC but not
AP-1-LUC is activated by TNF-a in Thy-12 MEF. In accord,
PP2 rescues activation of IL-8-LUCwt and IL-8-LUCmtAP-1
which harbor the intact NF-kB binding site, but not IL-8-
LUCmtNF-kB in Thy-1+ MEFs (Figure 7). Notably, TNF-a-
induced degradation of I-kBa, a pivotal step for activation of NF-
kB, is comparable between MEF Thy-1 subsets (Figure 3). This
piece of evidence indicates that Thy-1 modulates NF-kB activity in
an I-kBa independent manner. Our findings are reminiscent of a
previous observation that reveals equivalent receptor expression
and surface binding to IL-1b as well as the consequent NF-kB
activation in the rat lung fibroblast Thy-1 subsets, albeit greater
IL-6 induction by IL-1b is observed in Thy-12 subset [17]. In
summary, these results suggest that the transcriptional activity of
NF-kB is regulated by Thy-1 in fibroblasts after release from its
inhibitor I-kBa. The transcriptional activity of NF-kB might be
negatively regulated by Thy-1 via inhibition of SFK because PP2
rescues NF-kB-dependent gene activation and SFK activation by
TNF-a in Thy-1+ MEFs (Figures 3–7).
Our attempts to determine the Thy-1-modulated TNF-a
signaling pathway(s) have led to an unexpected finding in that a
commonly used SFK selective inhibitor PP2 displays minimal
effect on SFK activation as well as TNF-a-activated gene
expression in Thy-12 MEFs (Figures 3 & 4). In stark contrast to
its reported inhibition of SFK activation, not only did PP2 fail to
inhibit SFK and gene activation by TNF-a in Thy-12 MEFs, it
paradoxically rescued SFK activation and gene expression by
TNF-a in Thy-1+ MEFs (Figures 3 & 4). Consistent with the
remainder of our findings, another SFK selective inhibitor
Figure 6. Attenuated TNF-a-activated gene expression by dnFyn in Thy-1– MEF. The dnFyn expression vector or the backbone vector was
transiently transfected into Thy-1– MEF prior exposure to TNF-a. A & B) Serum-starved MEFs were exposed to TNF-a (5 ng/ml) for 24 hours. Total
cellular RNA was isolated and subject to quantitative RT-PCR for MMP-9 and ICAM-1, respectively. The fold change of each mRNA was obtained by
correction for the corresponding values of the house keeping gene 36B4 and by setting the values from the control group to one. The results are
presented as the mean and standard deviation from three independent transfections. *, P value,0.05. C) The conditioned medium was collected
from each treatment group and processed for gelatin zymography to determine the expression of MMP-9 in the conditioned medium. A
representative image is shown from two independent transfections.
doi:10.1371/journal.pone.0011662.g006
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by TNF-a in Thy-12 MEFs (Figure 5). The opposing effects of the
two SFK selective inhibitors, SU6656 and PP2, on the Thy-1
subsets concur in regard to the conclusion that SFK activation is
critical for TNF-a-activated gene expression in MEFs. Indeed, the
requirement of SFK activation for TNF-a-activated gene
expression in MEFs is further supported by a molecular SFK-
specific inhibitory approach. Expression of dominant-negative Fyn
significantly reduced gene activation by TNF-a in Thy-12 MEFs
(Figure 6). Thy-1 appears to down-regulate TNF-a-activated gene
expression via interfering with SFK activation. The unexpected
effect of PP2 on SFK activity could indicate that Thy-1 employs an
unidentified PP2-sensitive signaling pathway to inhibit SFK
activation and consequently the cellular responses to TNF-a in
fibroblasts. This speculation is supported by a recent report that
demonstrates PP2-mediated increase in phosphorylation at the
positive regulatory site Tyr-416 in Src and decrease in phosphor-
ylation at the negative regulatory site Tyr-529 [31]. The report
further suggests that the kinase Csk is the target of PP2 in
activation of Src because Csk phosphorylates Src at Tyr-529 and
its catalytic activity is inhibited by PP2. In line with this postulate,
Thy-1 exists in a multiple protein complex that contains both Csk
and Fyn, a SFK family member [2]. Expression of dominant-
negative Fyn abrogates TNF-a-activated gene expression
(Figure 6). Based on our results and others’ findings, we propose
that Thy-1 inhibits SFK, very likely Fyn, by promoting Csk
activity and PP2 rescues SFK activation by inhibiting Csk in Thy-
1+ MEFs. These findings warrant further investigation of the
functional interaction among Thy-1, Csk, and SFK in fibroblast in
the context of TNF-a-induced inflammatory response. The
unknown PP2-sensitive signaling pathway might be dependent
on specific cell or species type because PP2 abolishes SFK and the
consequent NF-kB activation by TNF-a in human epithelial cell
lines [23,24]. Exogenous expression of Thy-1 on Thy-1-nonex-
pressing fibroblasts results in inhibition of SFK activity and
subsequent activation of RhoA, leading to focal adhesion assembly
and stress fiber formation [5,27,28,29]. The cellular context
dependent modulation of SFK by Thy-1 is further illustrated by a
previous report that suggests Thy-1 is pivotal for thrombospondin-
1-mediated SFK activation as well as focal adhesion disassembly in
Figure 7. Activation of NF-kB-mediated gene expression by PP2 in Thy-1+ MEFs. A) MEF Thy-1 subsets were transfected with IL-8-LUC
reporter (IL-8-LUCwt) or its variants with either the NF-kB or the AP-1 binding sites mutated (IL-8-LUCmtNF-kB or IL-8-LUCmtAP-1). The reporter
activity was examined upon exposure to TNF-a. The ratios of IL-8-LUC variants vs. the cotransfected RL-TK were compared across the groups. B)
Similar to part A except that the activity of IL-8-LUC variants was examined in Thy-1+ MEFs exposed to TNF-a 6 PP2. C) Similar to part B except that
activity of NF-kB-LUC and AP-1-LUC was examined in Thy-1+ MEFs exposed to TNF-a 6 PP2. D) Similar to part C except that the experiments were
carried out in Thy-12 MEFs. The results are presented in mean and standard deviations obtained from at least three independent transfections
preformed in duplicates. * indicates a P value,0.05.
doi:10.1371/journal.pone.0011662.g007
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modulation of SFK by Thy-1 highlights the complexity of Thy-1
mediated signaling regulation and warrants further investigation of
the molecular determinants of Thy-1 actions, such as its linkage
with glycophosphatidylinositol and association with lipid rafts
[1,2,3]. The unexpected findings of PP2-mediated activation of
SFK in Thy-1+ MEFs raise caution in the design and
interpretation of experiments involving small molecule inhibitors
of SFK.
In summary, the current study reveals greater SFK activation
and gene expression in response to TNF-a in Thy-12 MEFs
compared with their Thy-1+ counterparts. Our results further
suggest that Thy-1 down-regulates TNF-a-activated gene expres-
sion by interfering with SFK activation and NF-kB-mediated
transactivation. These findings provide a novel mechanistic insight
to the distinct roles of Thy-1 subsets of fibroblasts in inflammation
and warrant further investigation of Thy-1-mediated regulation of
the TNF-a-SFK-NF-kB network in fibroblasts residing within
various tissues upon inflammation.
Materials and Methods
Reagents and Antibodies
Protease Inhibitor Cocktail and Phosphatase Inhibitor Cocktail
2 were purchased from Sigma (St. Louis, MO). The SFK selective
inhibitors PP2 and SU6656 were purchased from Calbiochem
(San Diego, CA). Recombinant mouse TNF-a and human TGF-
b1 were obtained from Peprotech (Rocky Hill, NJ). The reporter
constructs that express firefly luciferase regulated by the human
IL-8 promoter either inact (IL-8-LUCwt) or with the NF-kBo r
AP-1 binding elements mutated (IL-8-LUCmtNF-kB and IL-8-
LUCmtAP-1) were kindly provided by Dr. Gary Wu at the
University of Pennsylvania School of Medicine [26]. The
luciferase reporters that are regulated by multiple copies of either
NF-kB or AP-1 binding sites (NF-kB-LUC and AP-1-LUC) were
purchased from Promega. The pRL-TK vector expressing Renilla
luciferase driven by the thymidine kinase promoter was obtained
from Promega (Madison, WI). The dominant-negative Fyn mutant
(the K229M mutant) expressing vector (dnFyn) and the backbone
vector pCMV5 were kindly provided by Dr. Marylin Resh at the
Memorial Sloan Kettering Cancer Center [32]. Thy-1 expression
vector and the backbone vector pCDNA3.1.Zeo were generated as
previously described [5]. Rabbit polyclonal antibodies specific for
SFK, phospho-tyrosine, and a b-actin-specific goat polyclonal
antibody were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA). Rabbit polyclonal antibodies specific for c-Src with
tyrosine 416 phosphorylated (or other SFK members with
equivalent sites phosphorylated) and specific for I-kBa were
purchased from Cell Signaling Technology (Beverly, MA). A
rabbit polyclonal antibody specific for Focal Adhesion Kinase
(FAK) was purchased from Upstate (Lake Placid, NY). FITC-
labeled antibodies against Thy-1.1 and Thy-1.2 were purchased
from BD Biosciences (Bedford, MA).
Primary Fibroblasts Purification, Cell Sorting and Culture
Mouse embryonic fibroblasts (MEF) from C57 mice were
isolated and sorted with FACS using FITC-labeled Thy-1-specific
antibodies as previously described [15]. The purity of each subset
was above 95%. The sorted MEFs were cultured in DMEM
(Sigma, St. Louis, MO) supplemented with 10% FBS (vol/vol),
100 mg/ml penicillin and 100 mg/ml streptomycin in a humidified
incubator with 5% CO2. Two different batches of sorted Thy-1
subpopulations of MEFs were employed in this study and yielded
similar results. Two variant rat fetal lung fibroblast transfectants
(RFL6) were generated by introducing either the backbone vector
or the murine Thy-1.2 cDNA expression vector into RFL6 Thy-
12 cells as previously described [5] and hence were named as
RFL6.EV and RFL6.Thy-1, respectively. The RFL6 transfectants
were cultured in F12K (Invitrogen, Carlsbad CA) supplemented
with 10% FBS (vol/vol), 100 mg/ml penicillin, 100 mg/ml
streptomycin and the selecting reagent Zeocin (Invitrogen,
Carlsbad, CA). All the fibroblasts were serum-starved in the
appropriate medium containing 0.5% FBS for 48 hours prior to
exposure to the indicated doses of TNF-a or TGF-b1. In selected
experiments, the MEFs were pre-treated with PP2 (10 mM) or
SU6656 (20 mM) for 30 minutes followed by exposure to TNF-a
(5 ng/ml) for the indicated duration.
RNA Isolation, Reverse Transcription and Real-time PCR
Quantitative RT-PCR was performed to determine mRNA
levels of Genes Of Interest (GOI) in MEFs subject to the indicated
treatments as previously described [33]. The primers used were as
follows: mouse 36B4 (GenBank BC011106, conserved in rat
36B4), forward primer (nucleotides 69–88), 59-CGACCTG-
GAAGTCCAACTAC-39, and reverse primer (nucleotides 177–
160) 59-ATCTGCTGCATCTGCTTG-39; mouse ICAM-1 (Gen-
Bank NM_010493), forward primer (nucleotides 981–1000), 59-
GACGCAGAGGACCTTAACAG-39, and reverse primer (nucle-
otides 1119–1102), 59-GACGCCGCTCAGAAGAAC-39; mouse
MMP-9 (GenBank BC046991), forward primer (nucleotides 2033–
2052), 59-CCTGGAACTCACACGACATC-39, and reverse
primer (nucleotides 2261–2244), 59-GGTGGTGGTGGTGG-
TCTC-39. The ratio of GOI/36B4 was compared among samples
and the fold change of GOI expression was obtained by setting the
values from the untreated cells to one.
Gelatin Zymography
Serum-starved fibroblasts were exposed to the indicated doses of
TNF-a or TGF-b1 with or without pretreatment with PP2
(10 mM) or SU6656 (20 mM) for 30 minutes. The conditioned
medium was collected at 48 hours after the specified treatments
and processed for gelatin zymography as described elsewhere [33].
The intensity of MMP-9 gelatinlytic zones on the gels was
quantified by densitometry using the AlphaImager 2200 Docu-
mentation Analysis System with AlphaEase StandAlone Software
Version 5.04 (Alpha Innotech Corp., San Leandro, CA).
Invasion Assays
The invasive potential of TNF-a-stimulated MEFs was assessed
using the BD Biocoat Invasion System (BD Biosciences, Bedford
MA) following provided instructions. Briefly, serum-starved MEF
cells were seeded into the top chamber at a density of 1610
4 cells
per well. DMEM containing 5% FBS was added into the bottom
chamber as a chemoattractant. TNF-a (5 ng/ml) was added at
16 hours after seeding and left in the medium for another
24 hours. The non-invading cells on the top surface of the
membrane were removed by scrubbing twice with a swab. The
invading cells on the bottom surface of the membrane were stained
using Hema 3 system (Fisher Scientific, Middletown, VA).
Invading cells were enumerated under light microscopy. The
invasion assays were performed in triplicates for each treatment
group. Results shown were the average from three triplicates.
Immunoblots
The immunoblots for signaling molecules were carried out as
previously described [34]. Fibroblasts subject to the indicated
treatments (TNF-a 5 ng/ml 6 PP2 or SU6656) were lysed in 16
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was fractionated in an 8–16% gradient Tris-glycine Precast Gel
(Invitrogen) and transferred to a PVDF membrane (Bio-rad). The
blots were probed for protein levels of SFK, phospho-SFK and I-
kBa using the appropriate antibodies (anti-SFK, 1:500; anti-
phospho-SFK, 1:1000; anti-I-kB-a, 1:1000). To monitor the
loading variations, the blots were stripped and re-probed for b-
actin. The abundance of tyrosine-phosphorylated FAK associated
with SFK was measured by immunoblots using phosphor-tyrosine-
specific antibody (anti-Tyr-P, 1:500) on immunoprecipitates by
SFK-specific antibody as described in in vitro SFK kinase assay.
The total SFK-associated FAK was evaluated by immunoblot with
a FAK-specific antibody after stripping the blot.
In vitro SFK kinase assay
SFK catalytic activity in treated MEFs was analyzed using the
Src Assay Kit (Upstate, Lake Placid, NY) as per the provider’s
instructions. The cell extracts were prepared from the MEFs
subject to the indicated experimental conditions and immunopre-
cipitated with an SFK-specific antibody as described previously
[35]. Briefly, MEFs were pretreated with PP2 (10 mM) for 30
minutes followed by exposure to TNF-a (5 ng/ml) for another 5
minutes. The treated MEFs were then lysed in EBCD buffer
(50 mM Tris, pH 8.0, 120 mM NaCl, 0.5% Nonidet P-40, 5 mM
DTT). One milligram of each lysate was pre-cleared with BSA/
Protein G-agarose slurry (Invitrogen) followed by immunoprecip-
itation with 1 mg of SFK-specific antibody. The phosphotransfer-
ase activity of SFK in immunprecipitates was evaluated by
measuring the [c-32P] ATP incorporated into an SFK-specific
peptide substrate. The SFK activity for each sample was
determined after corrected with the values of immunoprecipitates
by a control rabbit IgG per recommendations in the provided
manual.
Transient Transfection and Luciferase Reporter assays
Transient transfection and luciferase reporter assays were
carried out as previously described [33]. Briefly, MEFs were
seeded into a 24-well culture plate at a density of 5610
4 cells per
well. On the next day, the two luciferase reporters IL-8-Luc and
pRL-TK were co-transfected into MEFs along with either the
backbone vectors or the vectors express mouse Thy-1 or dnFyn
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). The cells
were serum-starved for 24 hours after transfection and then
exposed to TNF-a (5 ng/ml) for 6 hours. The treated cells were
harvested and assayed for luciferase activity using the Lumat LB
9507 Luminometer (Berthold, Australia) along with the Dual-
Luciferase Reporter Assay System (Promega) per the provider’s
instructions. Variation in transfection efficiency was monitored
and corrected with the co-transfected pRL-TK. The ratio of Fire
Fly luciferase activity to Renilla luciferase activity in each sample
served as a measurement of normalized luciferase activity. The
fold change of normalized luciferase activity was obtained by
setting the values from the untreated cells at one. To determine the
effects of Thy-1 and dominant-negative Fyn on TNF-a-activated
gene expression, Thy-12 MEFs were transfected with either the
backbone vectors or Thy-1 or dn-Fyn vectors followed by
exposure to TNF-a. Total cell RNA (24 hr post-exposure to
TNF-a) or the conditioned medium (48 hrs post-exposure to TNF-
a) was collected to determine the expression of MMP-9 and
ICAM-1. To determine effects of PP2 on activity of the human IL-
8 promoter, IL-8-LUC and its variants with mutational inactiva-
tion of the NF-kB and AP-1 binding elements were transfected
into MEF Thy-1 subsets in the presence of TNF-a (5 ng/ml) 6
PP2 (10 mM). The transcriptional activity of NF-kB and AP-1 was
assessed by transfecting Thy-1+ MEFs with NF-kB-LUC and AP-
1-LUC in the presence or absence of TNF-a (5 ng/ml) 6 PP2
(10 mM).
Statistical Analyses
The results that were obtained from at least three independent
experiments were presented as mean6standard deviation. Statis-
tical evaluation was performed between individual treatment
groups by unpaired two-tailed Student’s T-test using GraphPad
Prism (GraphPad Software, version 3). A P value of less than 0.05
was considered significant.
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